Physician profile
Daniel Au
NPI 1346771151
$3,520.41
in general payments reported to CMS, 2019-2025
26 companies · $1,698 in 2025
The $1,698 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.39 · 2022: $563 · 2023: $695 · 2024: $532 · 2025: $1,698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,246 · Travel and Lodging: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,246.35 |
| Travel and Lodging | $677.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,238.85 | 2023-2025 | Lithovue, Ams 700, Lumenis Pulse 120h |
| Medtronic, INC. | $739.41 | 2025 | Altaviva, Interstim |
| Procept Biorobotics Corporation | $602.47 | 2022-2023 | Aquabeam Robotic System |
| Abbvie INC. | $115.99 | 2022-2023 | Botox, Lupron Depot |
| Angiodynamics, INC. | $85.32 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.79 | 2023-2024 | |
| Lsi Solutions INC | $59.25 | 2023 | Running Device, Jnw Urtrac |
| Merck Sharp & Dohme LLC | $54.62 | 2023-2024 | Lynparza, Keytruda |
| Urogen Pharma, INC. | $45.82 | 2023 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $45.33 | 2023-2024 | Pylarify |
| Sun Pharmaceutical Industries INC. | $43.95 | 2024 | |
| Coloplast Corp | $43.70 | 2022-2023 | Self-Cath |
| Astellas Pharma US INC | $43.43 | 2023 | Myrbetriq |
| Dendreon Pharmaceuticals LLC | $42.56 | 2022-2023 | Provenge |
| Myriad Genetic Laboratories, INC. | $37.41 | 2023 | Prolaris |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $36.36 | 2024 | |
| Intuitive Surgical, INC. | $33.39 | 2021 | |
| Axonics, INC. | $26.68 | 2024 | Bulkamid |
| Astrazeneca Pharmaceuticals Lp | $25.36 | 2023 | Lynparza |
| Vertex Pharmaceuticals Incorporated | $24.27 | 2025 | |
| Endo USA, INC. | $24.23 | 2024 | Xiaflex |
| Teleflex LLC | $22.03 | 2023 | Urolift |
| Accord Healthcare, INC. | $18.58 | 2024 | |
| Ethicon US, LLC | $18.21 | 2024 | Echelon; Endopath |
| Abc Home Medical Supply, INC. | $16.30 | 2025 | |
| Photocure INC | $14.10 | 2023 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Au listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.